Finance

Beta
Lists
HPHA:ETR
Heidelberg Pharma AG
€2.59
-2.63%
(-0.070) 1D
Jun 30, 5:35:22 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for HPHA...
Open
€2.60
High
€2.62
Low
€2.55
Mkt. cap
123.03M
Avg. vol.
2.82K
Volume
8.16K
52-wk high
€4.97
52-wk low
€2.33
EPS
-€0.87
Shares outstanding
46.78M
No. of employees
60
Open
€2.60
High
€2.62
Low
€2.55
Mkt. cap
123.03M
Avg. vol.
2.82K
Volume
8.16K
52-wk high
€4.97
52-wk low
€2.33
EPS
-€0.87
Shares outstanding
46.78M
No. of employees
60
News stories
From sources across the web
About Heidelberg Pharma AG
CEO-
Employees60
Founded1997
Headquarters-
SectorBiotechnology
Websiteheidelberg-pharma.com
Last report
Apr 29, 2026
Fiscal period
Q1 2026
EPS / Est. (EUR)
- / -
Revenue / Est. (EUR)
3.03M / -
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in EUR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in EUR
May 2025
Aug 2025
Nov 2025
Feb 2026
Revenue
118.51K
47.13K
21.44K
3.03M
Cost of goods sold
51.18K
86.71K
90.34K
374.20K
Cost of revenue
51.18K
86.71K
90.34K
374.20K
Research and development expenses
6.84M
7.59M
17.74M
6.07M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.83M
1.56M
2.61M
1.57M
Operating expense
8.98M
10.07M
22.12M
7.76M
Total operating expenses
9.03M
10.16M
22.21M
8.13M
Operating income
-8.91M
-10.11M
-22.19M
-5.10M
Other non operating income
1.97M
1.41M
-4.90M
1.04M
EBT including unusual items
-6.65M
-8.46M
-20.18M
-4.28M
EBT excluding unusual items
-6.65M
-8.46M
-20.31M
-4.28M
Income tax expense
-
-
1.05M
-
Effective tax rate
-
-
-5.21%
-
Other operating expenses
308.80K
921.96K
1.77M
110.93K
Net income
-6.65M
-8.46M
-21.23M
-4.28M
Net profit margin
-5,614.16%
-17,956.70%
-99,007.38%
-141.02%
Earnings per share
-
-
-
-
Interest and investment income
289.46K
234.16K
1.61M
87.21K
Interest expense
-1.32K
-1.14K
-926.00
-711.00
Net interest expenses
288.14K
233.02K
1.61M
86.50K
Depreciation and amortization charges
-
-
-
-
EBITDA
-8.70M
-9.89M
-22.13M
-5.03M
Gain or loss from assets sale
-
-92.00
4.07K
14.90K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer